Search Results - shalom+darmanjian

3 Results Sort By:
Star, Branched, and Graft Polymers in Binders for Inkjet Additive Manufacturing for Personalized Dosage Tablets
THE CHALLENGE A major problem posed by the pharmaceutical industry is giving effective dosages while not giving excessive amounts of a particular drug. An estimated 80% of side effects in humans and animals are a direct result of inaccurate dosing because varying weights in patients. Additive manufacturing has emerged as a very promising method to...
Published: 1/31/2024   |   Inventor(s): Emily Wilts, Timothy Long, Christopher Williams, Da Ma
Keywords(s):  
Category(s): Technology Classifications > Additive Manufacturing, Technology Classifications > Biomedical, Technology Classifications > Chemicals/Materials, Technology Classifications > Pharmacology and Therapeutics
Real-time Preeclampsia Monitoring and Detection Device
Detects Preeclampsia Early Warning Signs in Expecting Mothers to Minimize Mortality Sensors on this device attach to a patient’s body to monitor for physiological changes associated with preeclampsia symptoms. The device generates and reports derived data to healthcare professionals who can facilitate treatment and progress to delivery, which...
Published: 6/27/2021   |   Inventor(s): Tammy Euliano, Neil Euliano, Shalom Darmanjian
Keywords(s): preeclampsia, Preeclampsia prediction, Preeclampsia Screening Device, Screening Test
Category(s): Technology Classifications > Medical Devices > Equipment
Bi-Functional RGD Peptide and a Co-Signaling Mechanism to Promote Therapeutic Angiogenesis
Bi-Functional RGD Peptide to Promote Therapeutic Angiogenesis, Treat Ischemic Diseases Technology: While previous studies have focused on the identification of biological ligands to improve the functions of endothelial cells, MUSC and Clemson University researchers have combined modern bioinformatics and a newly established peptide functionalized...
Published: 3/23/2023   |   Inventor(s): Chung-Jen (James) Chou, Ying Mei, Jia Jia
Keywords(s):  
Category(s): BioPharma